跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lutaprost - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lutaprost
Approved
STANDARD
Lutaprost
Globela Pharma Private Limited.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6cb74e7d7143f6be
Company
Globela Pharma Private Limited.
Type
Standard
Approval Details
Approval Id
6cb74e7d7143f6be
Drug Approval Philippines Name
Lutaprost
Product Name
Lutaprost
Registration Number
DRP-15215
Brand Name
Lutaprost
Generic Name
Bicalutamide
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg
Manufacturer
Globela Pharma Private Limited.
Importer
AMB HK Enterprises Inc.
Distributor
AMB HK Enterprises Inc.
Issuance Date
29 May 2024
Expiry Date
29 May 2029
Pharmacologic Category
Antineoplastic
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6cb74e7d7143f6be
Type
Standard
Back to Philippines FDA Approvals